Alpha-synuclein Functions in the Nucleus to Protect Against Hydroxyurea-induced Replication Stress in Yeast

Overview

Journal Hum Mol Genet

Specialties Genetics
Molecular Biology

Date 2011 Jun 7

PMID 21642386

Citations 22

Authors

Xianpeng Liu

Yong Joo Lee

Liang-Chun Liou

Qun Ren

Zhaojie Zhang

Shaoxiao Wang

Stephan N Witt

Affiliations

Soon will be listed here.

Abstract

Hydroxyurea (HU) inhibits ribonucleotide reductase (RNR), which catalyzes the rate-limiting synthesis of deoxyribonucleotides for DNA replication. HU is used to treat HIV, sickle-cell anemia and some cancers. We found that, compared with vector control cells, low levels of alpha-synuclein (α-syn) protect S. cerevisiae cells from the growth inhibition and reactive oxygen species (ROS) accumulation induced by HU. Analysis of this effect using different α-syn mutants revealed that the α-syn protein functions in the nucleus and not the cytoplasm to modulate S-phase checkpoint responses: α-syn up-regulates histone acetylation and RNR levels, maintains helicase minichromosome maintenance protein complexes (Mcm2-7) on chromatin and inhibits HU-induced ROS accumulation. Strikingly, when residues 2-10 or 96-140 are deleted, this protective function of α-syn in the nucleus is abolished. Understanding the mechanism by which α-syn protects against HU could expand our knowledge of the normal function of this neuronal protein.

Citing Articles

Nuclear alpha-synuclein accelerates cell senescence and neurodegeneration.

Du T, Li G, Zong Q, Luo H, Pan Y, Ma K Immun Ageing. 2024; 21(1):47.

PMID: 38997709 PMC: 11242018. DOI: 10.1186/s12979-024-00429-0.

Special Issue "Neurobiology of Protein Synuclein".

Toni M Int J Mol Sci. 2024; 25(6).

PMID: 38542197 PMC: 10969974. DOI: 10.3390/ijms25063223.

Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma.

Arnold M, Cohn G, Oxe K, Elliott S, Moore C, Laraia P bioRxiv. 2024; .

PMID: 38260370 PMC: 10802588. DOI: 10.1101/2024.01.13.575526.

PPARs and Their Neuroprotective Effects in Parkinson's Disease: A Novel Therapeutic Approach in α-Synucleinopathy?.

Perez-Segura I, Santiago-Balmaseda A, Rodriguez-Hernandez L, Morales-Martinez A, Martinez-Becerril H, Martinez-Gomez P Int J Mol Sci. 2023; 24(4).

PMID: 36834679 PMC: 9963164. DOI: 10.3390/ijms24043264.

Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation.

Pieger K, Schmitt V, Gauer C, Giessl N, Prots I, Winner B Biomolecules. 2022; 12(8).

PMID: 36009004 PMC: 9406079. DOI: 10.3390/biom12081108.

References

Vamvaca K, Volles M, Lansbury Jr P . The first N-terminal amino acids of alpha-synuclein are essential for alpha-helical structure formation in vitro and membrane binding in yeast. J Mol Biol. 2009; 389(2):413-24. PMC: 2801807. DOI: 10.1016/j.jmb.2009.03.021. View

Elledge S . Cell cycle checkpoints: preventing an identity crisis. Science. 1996; 274(5293):1664-72. DOI: 10.1126/science.274.5293.1664. View

Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton M, Sudhof T . Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010; 329(5999):1663-7. PMC: 3235365. DOI: 10.1126/science.1195227. View

Conway K, Lee S, Rochet J, Ding T, Williamson R, Lansbury Jr P . Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A. 2000; 97(2):571-6. PMC: 15371. DOI: 10.1073/pnas.97.2.571. View

Perez-Sanchez F, Milan M, Buendia P, Cano-Jaimez M, Ambrosio S, Rosenthal A . Prosurvival effect of human wild-type alpha-synuclein on MPTP-induced toxicity to central but not peripheral catecholaminergic neurons isolated from transgenic mice. Neuroscience. 2010; 167(2):261-76. DOI: 10.1016/j.neuroscience.2010.02.016. View

Abou-Sleiman P, Healy D, Wood N . Causes of Parkinson's disease: genetics of DJ-1. Cell Tissue Res. 2004; 318(1):185-8. DOI: 10.1007/s00441-004-0922-6. View

Ibarra A, Schwob E, Mendez J . Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication. Proc Natl Acad Sci U S A. 2008; 105(26):8956-61. PMC: 2449346. DOI: 10.1073/pnas.0803978105. View

Haworth J, Alver R, Anderson M, Bielinsky A . Ubc4 and Not4 regulate steady-state levels of DNA polymerase-α to promote efficient and accurate DNA replication. Mol Biol Cell. 2010; 21(18):3205-19. PMC: 2938386. DOI: 10.1091/mbc.E09-06-0452. View

Binolfi A, Lamberto G, Duran R, Quintanar L, Bertoncini C, Souza J . Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation. J Am Chem Soc. 2008; 130(35):11801-12. DOI: 10.1021/ja803494v. View

10.

Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997; 276(5321):2045-7. DOI: 10.1126/science.276.5321.2045. View

11.

Outeiro T, Lindquist S . Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science. 2003; 302(5651):1772-5. PMC: 1780172. DOI: 10.1126/science.1090439. View

12.

Specht C, Tigaret C, Rast G, Thalhammer A, Rudhard Y, Schoepfer R . Subcellular localisation of recombinant alpha- and gamma-synuclein. Mol Cell Neurosci. 2005; 28(2):326-34. DOI: 10.1016/j.mcn.2004.09.017. View

13.

Woodward A, Gohler T, Luciani M, Oehlmann M, Ge X, Gartner A . Excess Mcm2-7 license dormant origins of replication that can be used under conditions of replicative stress. J Cell Biol. 2006; 173(5):673-83. PMC: 2063885. DOI: 10.1083/jcb.200602108. View

14.

Marchetti M, Weinberger M, Murakami Y, Burhans W, Huberman J . Production of reactive oxygen species in response to replication stress and inappropriate mitosis in fission yeast. J Cell Sci. 2005; 119(Pt 1):124-31. PMC: 1582148. DOI: 10.1242/jcs.02703. View

15.

Jensen P, Hojrup P, Hager H, Nielsen M, Jacobsen L, Olesen O . Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC. Biochem J. 1997; 323 ( Pt 2):539-46. PMC: 1218353. DOI: 10.1042/bj3230539. View

16.

Zhao X, Chabes A, Domkin V, Thelander L, Rothstein R . The ribonucleotide reductase inhibitor Sml1 is a new target of the Mec1/Rad53 kinase cascade during growth and in response to DNA damage. EMBO J. 2001; 20(13):3544-53. PMC: 125510. DOI: 10.1093/emboj/20.13.3544. View

17.

Gorbatyuk O, Li S, Nash K, Gorbatyuk M, Lewin A, Sullivan L . In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration. Mol Ther. 2010; 18(8):1450-7. PMC: 2927065. DOI: 10.1038/mt.2010.115. View

18.

Singleton A, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J . alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003; 302(5646):841. DOI: 10.1126/science.1090278. View

19.

Chandra S, Gallardo G, Fernandez-Chacon R, Schluter O, Sudhof T . Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell. 2005; 123(3):383-96. DOI: 10.1016/j.cell.2005.09.028. View

20.

Segurado M, Tercero J . The S-phase checkpoint: targeting the replication fork. Biol Cell. 2009; 101(11):617-27. DOI: 10.1042/BC20090053. View